GB Patent

GB0226076D0 — Improved formulations containing substituted imidazole derivatives

Assigned to RP Scherer Technologies LLC · Expires 2002-12-18 · 23y expired

What this patent protects

Patent listed against Imitrex.

Drugs covered by this patent

Patent Metadata

Patent number
GB0226076D0
Jurisdiction
GB
Classification
—
Expires
2002-12-18
Drug substance claim
No
Drug product claim
No
Assignee
RP Scherer Technologies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.